O08966 (S22A1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 101.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Solute carrier family 22 member 1 Alternative name(s): Organic cation transporter 1 Short name=mOCT1 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 556 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Translocates a broad array of organic cations with various structures and molecular weights including the model compounds 1-methyl-4-phenylpyridinium (MPP), tetraethylammonium (TEA), N-1-methylnicotinamide (NMN), 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP), the endogenous compounds choline, guanidine, histamine, epinephrine, adrenaline, noradrenaline and dopamine, and the drugs quinine, and metformin. The transport of organic cations is inhibited by a broad array of compounds like tetramethylammonium (TMA), cocaine, lidocaine, NMDA receptor antagonists, atropine, prazosin, cimetidine, TEA and NMN, guanidine, cimetidine, choline, procainamide, quinine, tetrabutylammonium, and tetrapentylammonium. Translocates organic cations in an electrogenic and pH-independent manner. Translocates organic cations across the plasma membrane in both directions. Transports the polyamines spermine and spermidine. Transports pramipexole across the basolateral membrane of the proximal tubular epithelial cells. The choline transport is activated by MMTS. Regulated by various intracellular signaling pathways including inhibition by protein kinase A activation, and endogenously activation by the calmodulin complex, the calmodulin-dependent kinase II and LCK tyrosine kinase. Ref.2 Ref.3 |
| Subcellular location | |
| Tissue specificity | Highly expressed in liver, kidney and intestine. Weakly expressed in adrenals and in lacting mammary glands. Ref.1 Ref.7 |
| Developmental stage | Weakly expressed 2 days before birth, but gradually increased during the first 3 weeks of age, reaching a plateau around day 22 in both kidney and liver. At 45 days of age, renal and hepatic levels is 4 to 6 times higher than the level immediately after birth. Ref.7 |
| Induction | Increased by PPARA and PPARG treatment in both liver and H35 cells. Ref.6 |
| Post-translational modification | Phosphorylated By similarity. |
| Sequence similarities | Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family. [View classification] |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 556 | 556 | Solute carrier family 22 member 1 | PRO_0000333876 | |||||
Regions | |||||||||
| Topological domain | 1 – 21 | 21 | Cytoplasmic Potential | ||||||
| Transmembrane | 22 – 42 | 21 | Helical; Potential | ||||||
| Topological domain | 43 – 150 | 108 | Extracellular Potential | ||||||
| Transmembrane | 151 – 171 | 21 | Helical; Potential | ||||||
| Topological domain | 172 – 177 | 6 | Cytoplasmic Potential | ||||||
| Transmembrane | 178 – 198 | 21 | Helical; Potential | ||||||
| Topological domain | 199 – 211 | 13 | Extracellular Potential | ||||||
| Transmembrane | 212 – 231 | 20 | Helical; Potential | ||||||
| Topological domain | 232 – 238 | 7 | Cytoplasmic Potential | ||||||
| Transmembrane | 239 – 259 | 21 | Helical; Potential | ||||||
| Topological domain | 260 – 263 | 4 | Extracellular Potential | ||||||
| Transmembrane | 264 – 284 | 21 | Helical; Potential | ||||||
| Topological domain | 285 – 348 | 64 | Cytoplasmic Potential | ||||||
| Transmembrane | 349 – 369 | 21 | Helical; Potential | ||||||
| Topological domain | 370 – 377 | 8 | Extracellular Potential | ||||||
| Transmembrane | 378 – 398 | 21 | Helical; Potential | ||||||
| Topological domain | 399 – 403 | 5 | Cytoplasmic Potential | ||||||
| Transmembrane | 404 – 424 | 21 | Helical; Potential | ||||||
| Topological domain | 425 – 429 | 5 | Extracellular Potential | ||||||
| Transmembrane | 430 – 452 | 23 | Helical; Potential | ||||||
| Topological domain | 453 – 465 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 466 – 486 | 21 | Helical; Potential | ||||||
| Topological domain | 487 – 493 | 7 | Extracellular Potential | ||||||
| Transmembrane | 494 – 514 | 21 | Helical; Potential | ||||||
| Topological domain | 515 – 556 | 42 | Cytoplasmic Potential | ||||||
Sites | |||||||||
| Site | 451 | 1 | Involved in affinity and selectivity of cations as well as in translocation By similarity | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 71 | 1 | N-linked (GlcNAc...) Potential | ||||||
Experimental info | |||||||||
| Sequence conflict | 26 | 1 | C → Y in AAB19097. Ref.1 | ||||||
| Sequence conflict | 144 | 1 | G → V in AAB19097. Ref.1 | ||||||
| Sequence conflict | 506 | 1 | S → T in AAB19097. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters." Schweifer N., Barlow D.P. Mamm. Genome 7:735-740(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY. Strain: C57BL/6. Tissue: Liver. |
| [2] | "Cloning and functional expression of a mouse liver organic cation transporter." Green R.M., Lo K., Sterritt C., Beier D.R. Hepatology 29:1556-1562(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION. Strain: C57BL/6 X CBA. |
| [3] | "Functional characterization of mouse cation transporter mOCT2 compared with mOCT1." Kakehi M., Koyabu N., Nakamura T., Uchiumi T., Kuwano M., Ohtani H., Sawada Y. Biochem. Biophys. Res. Commun. 296:644-650(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION. Strain: ddY. Tissue: Kidney. |
| [4] | "Genomic sequence analysis in the mouse T-complex region." Brathwaite M., Waeltz P., Qian Y., Dudekula D., Schlessinger D., Nagaraja R. Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: 129S6/SvEvTac. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: FVB/N. Tissue: Liver. |
| [6] | "Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma." Nie W., Sweetser S., Rinella M., Green R.M. Am. J. Physiol. 288:G207-G212(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INDUCTION. |
| [7] | "Tissue distribution and ontogeny of organic cation transporters in mice." Alnouti Y., Petrick J.S., Klaassen C.D. Drug Metab. Dispos. 34:477-482(2006) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U38652 mRNA. Translation: AAB19097.1. AF010259 mRNA. Translation: AAC98884.1. AF481054 Genomic DNA. Translation: AAM22157.1. BC021651 mRNA. Translation: AAH21651.1. |
| IPI | IPI00331032. |
| RefSeq | NP_033228.2. NM_009202.5. |
| UniGene | Mm.594. |
3D structure databases | |
| ProteinModelPortal | O08966. |
| SMR | O08966. Positions 158-306. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 10090.ENSMUSP00000024596. |
Proteomic databases | |
| PaxDb | O08966. |
| PRIDE | O08966. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000024596; ENSMUSP00000024596; ENSMUSG00000023829. |
| GeneID | 20517. |
| KEGG | mmu:20517. |
| UCSC | uc008akx.1. mouse. |
Organism-specific databases | |
| CTD | 6580. |
| MGI | MGI:108111. Slc22a1. |
Phylogenomic databases | |
| eggNOG | COG0477. |
| GeneTree | ENSGT00700000104151. |
| HOGENOM | HOG000234568. |
| HOVERGEN | HBG061545. |
| InParanoid | O08966. |
| KO | K08198. |
| OMA | TIYLQVQ. |
| OrthoDB | EOG4S4PG6. |
Gene expression databases | |
| Bgee | O08966. |
| Genevestigator | O08966. |
Family and domain databases | |
| InterPro | IPR020846. MFS_dom. IPR016196. MFS_dom_general_subst_transpt. IPR004749. Orgcat_transp. IPR005828. Sub_transporter. IPR005829. Sugar_transporter_CS. [Graphical view] |
| Pfam | PF00083. Sugar_tr. 1 hit. [Graphical view] |
| SUPFAM | SSF103473. MFS_gen_substrate_transporter. 1 hit. |
| TIGRFAMs | TIGR00898. 2A0119. 1 hit. |
| PROSITE | PS50850. MFS. 1 hit. PS00216. SUGAR_TRANSPORT_1. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 298731. |
| SOURCE | Search... |
Entry information
| Entry name | S22A1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: O08966 Secondary accession number(s): Q9R1Q4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
